I am pleased to share this link to the BMC Infectious Diseases supplement, “Testing for chronic hepatitis B and C – a global perspective.”
This supplement, timed to coincide with the 2017 World Hepatitis Summit currently ongoing in Brazil, includes important articles relating to the WHO 2017 Guidelines on hepatitis B and C testing, provides a host of information regarding the current hepatitis B and C space and recommends next steps that we can take as a global health community to tackle these diseases. More specifically, the supplement presents research on the diagnostic accuracy of hepatitis B and C testing (including the use of dried blood spots), a target product profile for optimising diagnosis of viraemic HCV infection in low- and middle-income countries, economic evaluations of testing methods, ways forward to reaching equitable hepatitis B and C testing globally, and much more.
As FIND - together with partners such as WHO and others - continues to contribute to hepatitis C elimination through our HEAD*-Start project, we look forward to participating in an ongoing dialogue with the global health diagnostic community on challenges and lessons learned within this disease space.
*Hepatitis c Elimination through Access to Diagnostics
On behalf of Francesco Marinucci, Head of FIND HCV/HIV
Link leads to: https://bmcinfectdis.biomedcentral.com/articles/supplements/volume-17-supplement-1